1
|
Hackett G, Kirby M, Rees RW, Jones TH, Muneer A, Livingston M, Ossei-Gerning N, David J, Foster J, Kalra PA, Ramachandran S. The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice. World J Mens Health 2023:41.e33. [PMID: 36876744 DOI: 10.5534/wjmh.221027] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2022] [Revised: 11/07/2022] [Accepted: 11/23/2022] [Indexed: 03/02/2023] Open
Abstract
Testosterone deficiency (TD) is an increasingly common problem with significant health implications, but its diagnosis and management can be challenging. A multi-disciplinary panel from BSSM reviewed the available literature on TD and provide evidence-based statements for clinical practice. Evidence was derived from Medline, EMBASE and Cochrane searches on hypogonadism, testosterone therapy (T Therapy) and cardiovascular safety from May 2017 to September 2022. This revealed 1,714 articles, including 52 clinical trials and 32 placebo-controlled randomised controlled trials. A total of twenty-five statements are provided, relating to five key areas: screening, diagnosis, initiating T Therapy, benefits and risks of T Therapy, and follow-up. Seven statements are supported by level 1 evidence, eight by level 2, five by level 3, and five by level 4. Recent studies have demonstrated that low levels of testosterone in men are associated with increased risk of incident type 2 diabetes mellitus, worse outcomes in chronic kidney disease and COVID 19 infection with increased all-cause mortality, along with significant quality of life implications. These guidelines should help practitioners to effectively diagnose and manage primary and age-related TD.
Collapse
Affiliation(s)
- Geoffrey Hackett
- Department of Urology, Spire Hospital, Little Aston, Birmingham, UK.,Department of Urology, Aston University, Birmingham, UK.
| | - Michael Kirby
- Trends in Urology and Men's Health, Letchworth, UK.,Faculty of Health & Human Sciences, University of Hertfordshire & The Prostate Centre, London, UK
| | - Rowland W Rees
- Department of Urology, University Hospital Southampton and UCLH, London, UK
| | - T Hugh Jones
- Department of Endocrinology, Barnsley Hospital, Barnsley, UK.,Department of Biochemistry, Royal Hallamshire Hospital, University of Sheffield Medical School, Sheffield, UK
| | - Asif Muneer
- Division of Surgery and Interventional Science, NIHR Biomedical Research Centre UCLH, London, UK
| | - Mark Livingston
- Department of Biochemistry, Black Country Pathology Services, Walsall Manor Hospital, Walsall, UK
| | - Nick Ossei-Gerning
- Cardiff and Vale NHS Trust, Cardiff, UK.,University of South Wales TDS, Bridgend, UK.,Department of Cardiology, University of Cape Coast, Cape Coast, Ghana
| | | | | | - Philip A Kalra
- Department of Nephrology, NCA, Salford Royal Hospital, Salford, UK
| | - Sudarshan Ramachandran
- Department of Clinical Biochemistry, University Hospitals Birmingham NHS Foundation Trust, Sutton Coldfield, West Midlands, UK
| |
Collapse
|
2
|
Deverill SJ, Menzies-Wilson R, Rees RW. Point of technique: Limited anterior scrotectomy and scrotoplasty for multiple epidermoid cysts of the scrotum. Journal of Clinical Urology 2021. [DOI: 10.1177/2051415820927820] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Multiple scrotal epidermoid cysts present a difficult challenge. Individual cyst excision for multiple cysts is painstaking, and there is a high risk of recurrence. If treated conservatively, multiple cysts may cause pain, become infected or cause problems with self-esteem due to the cosmetic appearance. We present a technique for excision of the anterior scrotal wall as a treatment for multiple scrotal epidermoid cysts. Level of evidence: Not applicable.
Collapse
|
3
|
Lemmens J, Peko Cohen L, Worsley PR, Everitt C, Broadbridge J, Gefen A, Rees RW, Drake M, Macaulay MC, Fader M, Bader DL. Magnetic resonance imaging to estimate tissue deformations during penile clamp application: A case series. Journal of Clinical Urology 2020. [DOI: 10.1177/2051415820920511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background:Penile clamps provide a means of preventing urinary incontinence in males following radical prostatectomy. In order for the devices to function, significant mechanical loads need to be applied to the penile tissues to close the urethra. However, such loads have the potential to cause damage to the vulnerable skin and underlying soft tissues. Accordingly, the study aimed to estimate the magnitudes of tissue deformations resulting from penile clamp application in three individual cases.Methods:Three individuals were recruited who currently use penile clamps to manage urinary incontinence following radical prostatectomy. Magnetic resonance images (MRI) of the penis were taken to produce a series of high contrast coronal and sagittal images both before and during the application of two commercially available clamps, modified for MRI compatibility. Tissue thickness measurements were estimated with the clamps in-situ and normalised to the unloaded baseline state.Results:The estimated magnitude of tissue deformations resulting from clamp application ranged between 68% and 84%. There were minimal differences in these deformations between the clamp designs, both of which appeared effective in closing the urethra. Local stress concentrations were observed in the tissues, which were deformed around the shape of the clamp.Conclusions:MRI enabled quantification of local tissue deformation during penile clamp application. The results revealed that clamps created large tissue deformations in all three cases, regardless of design. This information could inform the development of new clamp designs and materials to minimise the potential for tissue damage.Level of evidence:4
Collapse
Affiliation(s)
- Joe Lemmens
- School of Health Sciences, University of Southampton, UK
| | - Lea Peko Cohen
- Department of Biomedical Engineering, Tel Aviv University, Israel
| | | | | | | | - Amit Gefen
- Department of Biomedical Engineering, Tel Aviv University, Israel
| | | | - Marcus Drake
- University of Bristol, Bristol Urological Institute, UK
| | | | - Mandy Fader
- School of Health Sciences, University of Southampton, UK
| | - Dan L Bader
- School of Health Sciences, University of Southampton, UK
| |
Collapse
|
4
|
Muneer A, Fowler S, Ralph DJ, Summerton DJ, Rees RW. UK practice for penile prosthesis surgery: baseline analysis of the British Association of Urological Surgeons (BAUS) Penile Prosthesis Audit. BJU Int 2020; 127:326-331. [PMID: 32869902 DOI: 10.1111/bju.15219] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVES To undertake a prospective multicentre national audit of penile prosthesis practice in the UK over a 3-year period. PATIENTS AND METHODS Data were submitted by urological surgeons as part of the British Association of Urological Surgeons Penile Prosthesis National Audit. Patients receiving a penile prosthesis (inflatable or malleable) were included as part of a prospective registry over a 3-year period. Data were validated and then analysed using a software package (Tableau). RESULTS A total of 1071 penile prosthesis procedures were included from 22 centres. The three commonest aetiological factors for erectile dysfunction were diabetes, prostate surgery and Peyronie's disease. Of the recorded data, inflatable penile prostheses were the commonest devices implanted, with 665 devices used (62.1%), whereas malleable prostheses accounted for 14.2% of the implants. Recorded intra-operative complications included urethral injury (0.7%, n = 7), corporal perforation (1.1%, n = 12) and cross-over (0.6%, n = 6). Known postoperative complications were recorded in 9.8% of patients (74/752), with the two most frequently reported being postoperative penile pain (n = 11) and scrotal haematoma (n = 14). CONCLUSION This baseline analysis is the largest prospective registry of penile prostheses procedures to date. The data show that, over the 3-year collection period in the UK, there are now fewer surgeons performing the procedure, together with a reduction in the number of centres. Peri-operative complications were infrequent, and the rate of implant abortion (e.g. as a result of urethral injury) was very low. Further follow-up data will be required to publish long-term outcomes and patient satisfaction.
Collapse
Affiliation(s)
- Asif Muneer
- NIHR Biomedical Research Centre, University College London Hospital, London, UK.,Division of Surgery and Interventional Science UCL, London, UK
| | | | | | | | - Rowland W Rees
- University Hospitals Southampton NHS Trust, Southampton, UK
| | | |
Collapse
|
5
|
Lemmens JM, Broadbridge J, Macaulay M, Rees RW, Archer M, Drake MJ, Moore KN, Bader DL, Fader M. Tissue response to applied loading using different designs of penile compression clamps. Med Devices (Auckl) 2019; 12:235-243. [PMID: 31303800 PMCID: PMC6603992 DOI: 10.2147/mder.s188888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2018] [Accepted: 03/22/2019] [Indexed: 12/02/2022] Open
Abstract
Background: Penile compression devices (PCD) or clamps are applied to compress the urethra and prevent urinary incontinence (UI). PCDs are more secure and less likely to leak than pads, allowing men the opportunity to participate in short-term, vigorous activities. However, they are uncomfortable, can cause pressure ulcers (PU) and affect penile blood flow. No objective assessment of tissue health has been undertaken to assess and compare different PCD designs and to provide guidance on safe use. Objective: This study was designed to evaluate existing PCDs in terms of their physiological response and potential for pressure-induced injury. Design, setting and participants: Six men with post-prostatectomy UI tested four selected PCDs at effective pressures, in a random order, in a controlled laboratory setting. Outcome measurements and statistical analysis: Using objective methods for assessing skin injury, PCDs were measured in situ for their effects on circulatory impedance, interface pressures and inflammatory response. Results and limitations: There was evidence for PCD-induced circulatory impedance in most test conditions. Interface pressures varied considerably between both PCDs and participants, with a mean value of 137.4±69.7 mmHg. In some cases, penile skin was noted to be sensitive to loading with elevated concentration of the cytokine IL-1α after 10 mins wear, indicating an inflammatory response. IL-1α levels were restored to baseline 40 mins following PCD removal. Conclusion: Skin health measures indicated tissue and blood flow compromise during the 50 mins of testing using all PCDs. Although there was an elevation in pro-inflammatory cytokines, PCDs did not cause sustained irritation and skin health measures recovered 40 mins after PCD removal. This research indicates that application of a clamp for one hour with an equal clamp free time before reapplication is likely to be safe. Longer periods are often recommended by manufacturers but have yet to be tested.
Collapse
Affiliation(s)
- Joseph Mh Lemmens
- University of Southampton, School of Health Sciences, Southampton SO17 1BJ, UK
| | - Jackie Broadbridge
- University of Southampton, School of Health Sciences, Southampton SO17 1BJ, UK
| | - Margaret Macaulay
- University of Southampton, School of Health Sciences, Southampton SO17 1BJ, UK
| | - Rowland W Rees
- Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
| | - Matt Archer
- Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
| | - Marcus J Drake
- Bristol Urological Institute, Southmead Hospital, Bristol, BS10 5NB, UK
| | - Katherine N Moore
- Faculty of Nursing, University of Alberta, Edmonton, Alberta, T6G 1C9, Canada
| | - Dan L Bader
- University of Southampton, School of Health Sciences, Southampton SO17 1BJ, UK
| | - Mandy Fader
- University of Southampton, School of Health Sciences, Southampton SO17 1BJ, UK
| |
Collapse
|
6
|
Jasionowska S, Brunckhorst O, Rees RW, Muneer A, Ahmed K. Redo-urethroplasty for the management of recurrent urethral strictures in males: a systematic review. World J Urol 2019; 37:1801-1815. [PMID: 30877359 PMCID: PMC6717180 DOI: 10.1007/s00345-019-02709-7] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2018] [Accepted: 02/26/2019] [Indexed: 11/24/2022] Open
Abstract
Purpose Redo-urethroplasty is a challenge for any genitourethral surgeon, with a number of techniques previously described. This systematic review aims to identify the surgical techniques described in the literature and evaluate the evidence for their effectiveness in managing recurrent urethral strictures. Materials and methods A systematic review of the MEDLINE and EMBASE databases from 1945 to July 2018 was performed and the urethroplasty procedures were classified according to the site and surgical technique. Primary outcomes included success rates measured via re-stricture rates and the post-op maximum urinary flow rate. Secondary outcomes included complication rates and patient-reported quality of life. Results A total of 39 identified studies met the inclusion criteria. Twenty-two studies described the use of excision and primary anastomotic urethroplasty with success rates showing wide variability (58–100%). Success rates reported according to the site of the stricture also varied: bulbar (58–100%) and posterior (69–100%) recurrent strictures. One-stage substitution urethroplasty was described in 25 studies with success rates of 18–100%, with the best outcomes reported for bulbar (58–100%) and hypospadias-related (78.6–82%) strictures. Two-stage substitution urethroplasty was described in 12 studies with the success rates of 20–100%, with the best evidence related to hypospadias-related and posterior urethral strictures. The buccal mucosa graft was the graft source with the best evidence for substitution urethroplasty (18–100%). Conclusions Trends of effectiveness were identified for redo-urethroplasty modalities in different locations. However, the current levels of evidence are limited to small observational studies, highlighting the need for further larger prospective data to evaluate different techniques used for recurrent urethral strictures. Electronic supplementary material The online version of this article (10.1007/s00345-019-02709-7) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Sara Jasionowska
- MRC Centre for Transplantation, Guy's Hospital, King's College London, London, UK.,Department of Urology, King's College Hospital, London, UK
| | - Oliver Brunckhorst
- MRC Centre for Transplantation, Guy's Hospital, King's College London, London, UK.,Department of Urology, King's College Hospital, London, UK
| | - Rowland W Rees
- Urology Department, University Hospital Southampton, NHS Foundation Trust, Southampton, UK
| | - Asif Muneer
- Department of Urology, NIHR Biomedical Research Centre, University College Hospital, University College London Hospitals NHS Foundation Trust, London, UK
| | - Kamran Ahmed
- MRC Centre for Transplantation, Guy's Hospital, King's College London, London, UK. .,Department of Urology, King's College Hospital, London, UK.
| |
Collapse
|
7
|
Voss JN, Crick AP, Rees RW. Urethro-cutaneous fistula repair using a combination of buccal mucosal graft and pedicled gracilis muscular flap for high risk patients. Urol Case Rep 2018; 23:37-38. [PMID: 30560057 PMCID: PMC6290253 DOI: 10.1016/j.eucr.2018.12.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2018] [Accepted: 12/04/2018] [Indexed: 11/19/2022] Open
Affiliation(s)
- James N. Voss
- Department of Urology, University Hospital Southampton, United Kingdom
| | - Alexandra P. Crick
- Department of Plastic Surgery, Salisbury District Hospital, United Kingdom
| | - Rowland W. Rees
- Department of Urology, University Hospital Southampton, United Kingdom
- Corresponding author. Department of Urology, University Hospital Southampton, Tremona Road, Southampton, SO16 6YD, United Kingdom.
| |
Collapse
|
8
|
Lucky M, Brown G, Dorkin T, Pearcy R, Shabbir M, Shukla CJ, Rees RW, Summerton DJ, Muneer A. British Association of Urological Surgeons (BAUS) consensus document for the management of male genital emergencies - testicular trauma. BJU Int 2018; 121:840-844. [DOI: 10.1111/bju.14163] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Marc Lucky
- Department of Urology; Aintree University Hospitals NHS Foundation Trust; Liverpool UK
| | - Gareth Brown
- Department of Urology; Royal Glamorgan Hospital; Llantrisant UK
| | - Trevor Dorkin
- Department of Urology; Freeman Hospital; Newcastle NHS Foundation Trust; Newcastle upon Tyne UK
| | | | - Majid Shabbir
- Department of Urology; Guy's and Saint Thomas’ NHS Foundation; London UK
| | | | - Rowland W. Rees
- Department of Urology; University Hospital Southampton NHS Foundation; Southampton UK
| | | | - Asif Muneer
- Department of Urology and NIHR Biomedical Research Centre; University College London Hospital; London UK
| | | |
Collapse
|
9
|
Muneer A, Brown G, Dorkin T, Lucky M, Pearcy R, Shabbir M, Shukla CJ, Rees RW, Summerton DJ. BAUS consensus document for the management of male genital emergencies: priapism. BJU Int 2018; 121:835-839. [PMID: 29357203 DOI: 10.1111/bju.14140] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Male genital emergencies relating to the penis and scrotum are rare and require prompt investigation and surgical intervention. Clinicians are often unfamiliar with the management of these conditions and may not work in a specialist centre with on-site expertise in genitourethral surgery. A series of consensus statements have been developed by an expert consensus committee comprising members of the BAUS Section of Andrology and Genitourethral Surgery together with experts from urology units throughout the UK. Priapism requires prompt assessment and treatment and these consensus statements provide guidance for UK practice.
Collapse
Affiliation(s)
| | - Asif Muneer
- Department of Urology and NIHR Biomedical Research Centre, University College London Hospital, London, UK
| | - Gareth Brown
- Department of Urology, Royal Glamorgan Hospital, Llantrisant, UK
| | - Trevor Dorkin
- Department of Urology, Freeman Hospital, Newcastle upon Tyne, UK
| | - Marc Lucky
- Department of Urology, Aintree University Hospitals NHS Foundation Trust, Liverpool, UK
| | | | - Majid Shabbir
- Department of Urology, Guy's and Saint Thomas' NHS Foundation Trust, London, UK
| | | | - Rowland W Rees
- Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK
| | | |
Collapse
|
10
|
Rees RW, Brown G, Dorkin T, Lucky M, Pearcy R, Shabbir M, Shukla CJ, Summerton DJ, Muneer A. British Association of Urological Surgeons (BAUS) consensus document for the management of male genital emergencies - penile fracture. BJU Int 2018; 122:26-28. [PMID: 29438589 DOI: 10.1111/bju.14167] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Male genital emergencies relating to the penis and scrotum are rare and require prompt investigation and surgical intervention. Clinicians are often unfamiliar with the management of these conditions and may not work in a specialist centre with on-site expertise in genitourethral surgery. The aim of these consensus statements is to provide best practice guidance for urological surgeons based in the UK which are developed by an expert consensus. Penile fracture is a rare emergency and in most cases requires prompt exploration and repair to prevent erectile dysfunction and penile curvature.
Collapse
Affiliation(s)
- Rowland W Rees
- Department of Urology, University Hospital Southampton NHS Foundation, Southampton, UK
| | - Gareth Brown
- Department of Urology, Royal Glamorgan Hospital, Llantrisant, Rhondda Cynon Taf, UK
| | - Trevor Dorkin
- Department of Urology, Freeman Hospital, Newcastle NHS Foundation Trust, Newcastle upon Tyne, UK
| | - Marc Lucky
- Department of Urology, Aintree University Hospitals NHS Foundation Trust, Liverpool, UK
| | | | - Majid Shabbir
- Department of Urology, Guy's and Saint Thomas' NHS Foundation, London, UK
| | | | | | - Asif Muneer
- Department of Urology and NIHR Biomedical Research Centre, University College London Hospital, London, UK
| | | |
Collapse
|
11
|
Shukla CJ, Brown G, Dorkin T, Lucky M, Pearcy R, Rees RW, Shabbir M, Summerton DJ, Muneer A. British Association of Urological Surgeons (BAUS) consensus document for the management of male genital emergencies - penile amputation. BJU Int 2018; 121:699-702. [PMID: 29331084 DOI: 10.1111/bju.14135] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Male genital emergencies relating to the penis and scrotum are rare and require prompt investigation and surgical intervention. Clinicians are often unfamiliar with the management of these conditions and may not work in a specialist centre with on-site expertise in genitourethral surgery. A series of consensus statements have been developed by an expert consensus committee comprising members of the British Association of Urological Surgeons (BAUS) Section of Andrology and Genitourethral Surgery together with experts from urology units throughout the UK. Penile amputation is a rare genital emergency, which requires prompt intervention and microsurgical reconstruction. The consensus statements will outline the management of these cases for non-specialist units, as well as recommendations for reconstruction for specialists.
Collapse
Affiliation(s)
| | - Gareth Brown
- Department of Urology, Royal Glamorgan Hospital, Llantrisant, Rhondda Cynon Taf, UK
| | - Trevor Dorkin
- Department of Urology, Freeman Hospital, Newcastle upon Tyne, UK
| | - Marc Lucky
- Department of Urology, Aintree University Hospitals NHS Foundation Trust, Liverpool, UK
| | | | - Rowland W Rees
- Department of Urology, University Hospital Southampton NHS Foundation, Southampton, UK
| | - Majid Shabbir
- Department of Urology, Guy's and Saint Thomas' NHS Foundation Trust, London, UK
| | | | - Asif Muneer
- Department of Urology and NIHR Biomedical Research Centre University College London Hospital, London, UK
| | | |
Collapse
|
12
|
Abstract
OBJECTIVE We review the English literature between 1980 and 2013 and summarize the clinical classification, aetiology, physiology, and pathophysiology of paediatric priapism. We propose a clinical guideline for the management of priapism in children. PATIENTS Male patients aged ≤ 18 years. RESULTS Priapism, a prolonged penile erection lasting >4 h, is a rare condition in childhood. There are 3 widely accepted types of priapism: 1) ischaemic priapism, the commonest type seen in children; 2) stuttering priapism, recurrent, self-limiting prolonged erections; and 3) non-ischaemic priapism, rare in children, usually due to trauma. Neonatal priapism has also been described. Ischaemic priapism is a urological emergency causing fibrosis of the corpora cavernosa, subsequent erectile dysfunction and penile disfigurement. The commonest causes of priapism in children are sickle cell disease (65%), leukaemia (10%), trauma (10%), idiopathic (10%), and pharmacologically induced (5%). CONCLUSIONS Priapism in children must be assessed urgently. Rapid resolution of ischaemic priapism prevents permanent cavernosal structural damage and is associated with improved prognosis for potency later in life. Stuttering priapism requires careful counselling for episodic management. Chronic prophylaxis may be obtained using α-adrenergic sympathomimetics, phosphodiesterase type 5 inhibitors and, in sickle cell disease, hydroxyurea. Non-ischaemic and neonatal priapism may generally be treated less urgently.
Collapse
Affiliation(s)
- James F Donaldson
- Department of Paediatric Urology, University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, Hampshire SO16 6YD, UK.
| | - Rowland W Rees
- Department of Urological Surgery, University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, Hampshire SO16 6YD, UK.
| | - Henrik A Steinbrecher
- Department of Paediatric Urology, University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, Hampshire SO16 6YD, UK.
| |
Collapse
|
13
|
Donaldson JF, Rees RW, Steinbrecher HA. Response to Commentary to 'Priapism in children: a comprehensive review and clinical guideline'. J Pediatr Urol 2014; 10:25. [PMID: 24172798 DOI: 10.1016/j.jpurol.2013.09.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/10/2013] [Accepted: 09/11/2013] [Indexed: 11/16/2022]
Affiliation(s)
- James Fergus Donaldson
- University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, United Kingdom.
| | - Rowland W Rees
- University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, United Kingdom
| | - Henrik A Steinbrecher
- University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, United Kingdom
| |
Collapse
|
14
|
Alnajjar HM, Lam W, Bolgeri M, Rees RW, Perry MJ, Corbishley CM, Watkin NA. 670 TREATMENT OF CARCINOMA IN-SITU OF THE PENIS WITH TOPICAL CHEMOTHERAPY. J Urol 2012. [DOI: 10.1016/j.juro.2012.02.751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
15
|
Alnajjar HM, Perry MJ, Rees RW, Corbishley CM, Watkin NA. 751 OPTIMAL FOLLOW-UP ARRANGEMENTS FOR INVASIVE SQUAMOUS CARCINOMA OF THE PENIS. J Urol 2012. [DOI: 10.1016/j.juro.2012.02.837] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
16
|
Alnajjar HM, Perry MJ, Rees RW, Corbishley CM, Watkin NA. 752 LONG-TERM SURVIVAL OF PRIMARY PENILE CANCER IN A SUPRA-REGIONAL CENTRE. J Urol 2012. [DOI: 10.1016/j.juro.2012.02.838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Alnajjar HM, Lam W, Bolgeri M, Rees RW, Perry MJA, Watkin NA. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol 2012; 62:923-8. [PMID: 22421082 DOI: 10.1016/j.eururo.2012.02.052] [Citation(s) in RCA: 94] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2012] [Accepted: 02/29/2012] [Indexed: 11/26/2022]
Abstract
BACKGROUND The use of topical agents in the treatment of carcinoma in situ (CIS) of the penis has been well described in the literature. Previous studies have been limited by small sample size and imprecise end points. OBJECTIVE Establish the response rate of 5-fluorouracil (5-FU) and imiquimod (IQ) in the treatment of penile CIS in a large contemporary series in a supranetwork centre. DESIGN, SETTING, AND PARTICIPANTS Retrospective review of all primary and recurrent cases of penile CIS treated with 5-FU and IQ identified from a prospective database over a 10-yr period. Therapy was standardised in all cases with application to the lesion for 12h every 48 h for 28 d. INTERVENTION 5-FU was the first-line therapy, and IQ was the second-line topical agent. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS The primary end point was defined as complete response (CR; i.e., resolution of lesion), partial response (PR; i.e., lesion reduced in size and or visibility), or no response (NR; ie, no improvement in lesion size and or visibility). The secondary end points included local toxicity and adverse events. No statistical analysis or software was used. RESULTS AND LIMITATIONS A total of 86 patients were diagnosed with CIS of the penis over the 10-yr period. Forty-four (51%) received topical chemotherapy. The mean follow-up was 34 mo. CR to topical chemotherapy was seen in 25 (57%), PR was seen in 6 (13.6%), and NR was seen in the remaining 13 (29.5%) patients. Local toxicity was experienced by 10% of patients, and 12% had an adverse event following application of 5-FU. The retrospective design and short follow-up were the major limitations of this study. CONCLUSIONS Topical chemotherapy agents are moderately effective first-line therapy in the treatment of penile CIS. Toxicity and adverse events were few with our treatment protocol. The issues of long-term surveillance and assessment of partial responders remain a challenge. Topical chemotherapy should remain a first-line treatment option for penile CIS.
Collapse
|
18
|
Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith C, Ellis N, Fisher PAG, Van Haselen RA. Acupuncture for migraine and chronic tension headache in primary care: a large, pragmatic, randomised trial. ACTA ACUST UNITED AC 2010. [DOI: 10.1111/j.2042-7166.2003.tb04082.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
19
|
Brown GM, Khadra A, Abdelraheem A, Garaffa G, Freeman A, Rees RW, Muneer A, Ralph DJ, Minhas S. PREDICTORS OF PENILE CANCER RECURRENCE FOLLOWING CONSERVATIVE SURGICAL RESECTION. J Urol 2009. [DOI: 10.1016/s0022-5347(09)60580-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
20
|
Garaffa G, Muneer A, Freeman A, Abdel Raheem AM, Ralph DJ, Minhas S, Rees RW. Paraganglioma of the spermatic cord: case report and review of the literature. ScientificWorldJournal 2008; 8:1256-8. [PMID: 19112537 PMCID: PMC5849074 DOI: 10.1100/tsw.2008.161] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Paragangliomas rarely involve the genitourinary tract. We present a case of a paraganglioma arising from the spermatic cord and review the literature on the topic.
Collapse
Affiliation(s)
- Giulio Garaffa
- Department of Andrology, The Institute of Urology, University College London Hospitals, UK.
| | | | | | | | | | | | | |
Collapse
|
21
|
Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith CM, Ellis N, Fisher P, Van Haselen R, Wonderling D, Grieve R. Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis. Health Technol Assess 2004; 8:iii, 1-35. [PMID: 15527670 DOI: 10.3310/hta8480] [Citation(s) in RCA: 99] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
OBJECTIVES To determine the effects of a policy of using acupuncture, compared with a policy of avoiding acupuncture, on headache in primary care patients with chronic headache disorders. The effects of acupuncture on medication use, quality of life, resource use and days off sick in this population and the cost-effectiveness of acupuncture were also examined. DESIGN Randomised, controlled trial. SETTING General practices in England and Wales. PARTICIPANTS The study included 401 patients with chronic headache disorder, predominantly migraine. INTERVENTIONS Patients were randomly allocated to receive up to 12 acupuncture treatments over 3 months or to a control intervention offering usual care. MAIN OUTCOME MEASURES Outcome measures included headache score; assessment of Short Form 36 (SF-36) health status and use of medication at baseline, 3 months and 12 months; assessment of use of resources every 3 months; and assessment of incremental cost per quality-adjusted life-year (QALY) gained. RESULTS Headache score at 12 months, the primary end-point, was lower in the acupuncture group than in controls. The adjusted difference between means was 4.6. This result was robust to sensitivity analysis incorporating imputation for missing data. Patients in the acupuncture group experienced the equivalent of 22 fewer days of headache per year. SF-36 data favoured acupuncture, although differences reached significance only for physical role functioning, energy and change in health. Compared with controls, patients randomised to acupuncture used 15% less medication, made 25% fewer visits to GPs and took 15% fewer days off sick. Total costs during the 1-year period of the study were on average higher for the acupuncture group than for controls because of the acupuncture practitioners' costs. The mean health gain from acupuncture during the year of the trial was 0.021 QALYs, leading to a base-case estimate of GBP9180 per QALY gained. This result was robust to sensitivity analysis. Cost per QALY dropped substantially when the analysis incorporated likely QALY differences for the years after the trial. CONCLUSIONS The study suggests that acupuncture leads to persisting, clinically relevant benefits for primary care patients with chronic headache, particularly migraine. It is relatively cost-effective compared with a number of other interventions provided by the NHS. Further studies could examine the duration of acupuncture effects beyond 1 year and the relative benefit to patients with migraine with compared to tension-type headache. Trials are also warranted examining the effectiveness and cost-effectiveness of acupuncture in patients with headache receiving more aggressive pharmacological management.
Collapse
Affiliation(s)
- A J Vickers
- Integrative Medicine Service, Biostatistics Service, Memorial Sloan-Kettering Cancer Center, New York, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Rees RW, Foxwell NA, Ralph DJ, Kell PD, Moncada S, Cellek S. Y-27632, A Rho-Kinase Inhibitor, Inhibits Proliferation and Adrenergic Contraction of Prostatic Smooth Muscle Cells. J Urol 2003; 170:2517-22. [PMID: 14634463 DOI: 10.1097/01.ju.0000085024.47406.6c] [Citation(s) in RCA: 87] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
PURPOSE Benign prostatic hyperplasia (BPH) causes mechanical urinary flow obstruction by 2 components, namely an enlarged prostate (static component) and elevated smooth muscle tone (dynamic component). Currently available treatments for BPH aim to inhibit the proliferation of prostatic cells or decrease the elevated tone. To our knowledge no single agent that can achieve these 2 ends has yet been identified. A specific inhibitor of Rho-kinase, Y-27632 ((+)-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide dihydrochloride), has been demonstrated to cause smooth muscle relaxation and inhibit smooth muscle cell proliferation. Therefore, we investigated the effect of Y-27632 on prostatic smooth muscle proliferation and tone. MATERIALS AND METHODS Rho-kinase expression was investigated by immunocytochemistry and immunoblotting in smooth muscle cells obtained from rat and human prostates. The effect of Y-27632 was examined on the proliferation of these cells and on the contractions elicited by electrical field stimulation and exogenous phenylephrine in rat prostatic strips. RESULTS Immunoblot and immunofluorescence analysis showed that Rho-kinase is present in the cytosol and located in the perinuclear region in human and rat prostatic smooth muscle cells. Y-27632 decreased the proliferation of human and rat prostatic smooth muscle cells, and inhibited noradrenergic contractions elicited by electrical field stimulation and exogenous phenylephrine in rat prostatic strips (EC50 17.8 +/- 4.8 and 7.8 +/- 2.1 microM, respectively). CONCLUSIONS To our knowledge we report the first demonstration of the presence of Rho-kinase in prostatic smooth muscle cells, and of the relaxant and antiproliferative effect of a Rho-kinase inhibitor. We suggest a novel use for Rho-kinase inhibitors in the treatment of BPH as a single agent with dual action.
Collapse
Affiliation(s)
- Rowland W Rees
- Wolfson Institute for Biomedical Research, University College London, United Kingdom
| | | | | | | | | | | |
Collapse
|
23
|
Kalsi JS, Rees RW, Hobbs AJ, Royle M, Kell PD, Ralph DJ, Moncada S, Cellek S. BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro. J Urol 2003; 169:761-6. [PMID: 12544359 DOI: 10.1097/01.ju.0000043880.58140.69] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
PURPOSE In cavernous smooth muscle nitric oxide (NO) activates soluble guanylate cyclase, which catalyzes the synthesis of cyclic guanosine 3',5'-monophosphate, leading to smooth muscle relaxation, increased blood flow and penile erection. The pyrazolopyridine derivative BAY41-2272 (5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4ylamine) was identified and found to stimulate soluble guanylate cyclase in a NO independent manner. We investigated the effect of BAY41-2272 on human and rabbit corpus cavernosum. MATERIALS AND METHODS We investigated the effect of BAY41-2272 on the tone and nitrergic relaxation responses of human and rabbit cavernous strips in the absence and presence of the soluble guanylate cyclase inhibitor ODQ (1H-[1,2,4]oxadiazolo[4-3a]quinoxalin-1-one) or the NO synthase inhibitor L-NAME (N-nitro-L-arginine-methyl ester HCl). The potency of BAY41-2272 was compared to that of another soluble guanylate cyclase activator YC-1, and the NO releasing compound spermine NONOate (N-2-aminoethyl-N-2-hydroxy-2-nitrosohydroazino-1,2-ethylenediamine). RESULTS BAY41-2272 resulted in concentration dependent relaxation of human and rabbit cavernosum (mean EC50 +/- SEM 489.1 +/- 22.5 and 406.3 +/- 21.5 nM., respectively). The compound was 32 times more potent than YC-1 and twice as potent as spermine-NONOate. ODQ decreased the potency of BAY41-2272, such that in the presence of 30 microM. ODQ the EC50 of BAY41-2272 induced relaxation was 1,407.3 +/- 158.0 and 1,902.7 +/- 11.0 nM. in human and rabbit tissues, respectively. L-NAME also inhibited relaxations elicited by BAY41-2272 in rabbit tissue. In the presence of 500 microM. L-NAME the EC50 of BAY41-2272 induced responses was 836.7 +/- 46.7 nM. BAY41-2272 at subthreshold concentrations of 30 to 50 nM. potentiated nitrergic responses. Moreover, the inhibition of nitrergic responses by L-NAME was reversed by 0.3 to 3 microM. BAY41-2272. CONCLUSIONS We report that a nonNO based soluble guanylate cyclase activator relaxes human and rabbit corpus cavernosum, and potentiates nitrergic responses.
Collapse
Affiliation(s)
- Jas S Kalsi
- Wolfson Institute for Biomedical Research, University College London, United Kingdom
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
OBJECTIVE To evaluate the outcome of patients undergoing the immediate insertion of a penile prosthesis as a treatment for acute low-flow priapism. PATIENTS AND METHODS Eight patients presenting with low-flow priapism with a mean duration of 91 h (range 32-192) were prospectively evaluated. All had failed conservative management with the instillation of alpha-adrenergic agents, and four had already undergone shunt procedures elsewhere. Immediate management consisted of the insertion of a malleable prosthesis in six patients and an inflatable prosthesis in two. One of the malleable prostheses was subsequently changed to an inflatable device. RESULTS There were no early complications, with all patients being satisfied with the end result, and seven having sexual intercourse. One patient developed a penile deformity after surgery, cause by fibrosis around one inflatable cylinder. All patients have maintained their penile length. CONCLUSIONS Prolonged low-flow priapism results in a variable degree of cavernosal fibrosis and a subsequent loss of penile length. The delayed insertion of a penile prosthesis can be difficult, with high complication rates. The immediate insertion of a penile prosthesis in patients with prolonged low-flow priapism is simple and maintains penile length. This should always be offered to the patient at initial presentation, as the complication rate is low and the subsequent outcome excellent.
Collapse
Affiliation(s)
- R W Rees
- Institute of Urology, London, UK
| | | | | | | | | | | |
Collapse
|
25
|
Cellek S, Rees RW, Kalsi J. A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction. Expert Opin Investig Drugs 2002; 11:1563-73. [PMID: 12437503 DOI: 10.1517/13543784.11.11.1563] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Approximately 50% of men aged over 40 suffer from male erectile dysfunction. Treatment options have widened since the launch of the phosphodiesterase type 5 (PDE5) inhibitor, sildenafil citrate (Viagra trade mark ). However, a certain portion of the patient population, such as diabetics, do not gain significant benefit from PDE5 inhibitors, possibly due to a lack of endogenous nitric oxide. Therefore, new treatment modalities based on the absence of endogenous nitric oxide have been developed. Among them are Rho-kinase inhibitors, soluble guanylate cyclase activators and nitric oxide-releasing PDE5 inhibitors. The available data concerning these compounds will be summarised and their therapeutic potential for male erectile dysfunction will be discussed.
Collapse
Affiliation(s)
- Selim Cellek
- Wolfson Institute for Biomedical Research, University College London, Gower Street, Cruciform Building, London WC1E 6BT, UK
| | | | | |
Collapse
|
26
|
Abstract
DNA repair efficiency may play a significant role in individual susceptibility to bladder cancer, the third most common cancer in Europe. Bladder cancer arises from the urothelial cell layer which lines the urinary tract. As DNA repair gene expression levels should reflect DNA repair capacity, we investigated the expression of genes from the base excision, nucleotide excision and mismatch repair pathways in normal human urothelial (NHU) cells in vitro. RNA was extracted from six independent NHU cell lines and expression of 26 DNA repair genes was determined by ribonuclease protection assay. The results show that all the genes analysed were detected in NHU cells in vitro with a similar expression pattern in most cell lines. However, there was some variation between cell lines, with one expressing base excision repair genes very strongly, but another having weak expression of mismatch repair genes. These results suggest that DNA repair genes are constitutively expressed by NHU cells and that there is some inter-individual variation. Prospective studies are required to determine whether these differences in gene expression may play a role in susceptibility to bladder cancer.
Collapse
Affiliation(s)
- R A Crallan
- Jack Birch Unit for Molecular Carcinogenesis, Department of Biology, University of York, UK
| | | | | | | |
Collapse
|
27
|
Abstract
Penile erection is dependent upon vascular smooth muscle relaxation in erectile tissue and penile arteries, the principal mediator of relaxation being nitric oxide (NO). Evidence from basic scientific studies indicates that oxidative stress mediated through the superoxide radical (superoxide) and other reactive oxygen species (ROS) may be central to impaired cavernosal function in erectile dysfunction (ED). Increased inactivation of NO by superoxide results in impaired penile NO transmission and smooth muscle relaxation. Furthermore, propagation of endothelial dysfunction by ROS may result in chronic impairment of penile vascular function, a process analogous to early atherogenesis. Indeed, ED and atherosclerosis are closely linked through shared risk factors. Given our current understanding of ED pathophysiology, antioxidants may be of benefit in both the short- and long-term. Evidence supporting the paradigm of antioxidant therapy for the prevention or treatment of ED is presented herein.
Collapse
Affiliation(s)
- R W A Jones
- Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW, UK
| | | | | | | | | | | |
Collapse
|
28
|
Rees RW, Ziessen T, Ralph DJ, Kell P, Moncada S, Cellek S. Human and rabbit cavernosal smooth muscle cells express Rho-kinase. Int J Impot Res 2002; 14:1-7. [PMID: 11896471 DOI: 10.1038/sj.ijir.3900814] [Citation(s) in RCA: 62] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2001] [Revised: 10/10/2001] [Accepted: 10/23/2001] [Indexed: 11/08/2022]
Abstract
Rho-kinase is an enzyme involved in the Ca2+-sensitizing pathway in smooth muscle cells. Inhibition of this enzyme has been recently demonstrated to elicit penile erection by relaxing cavernosal smooth muscle. We aimed to investigate the presence and activity of Rho-kinase in human cavernosal smooth muscle. Primary culture of smooth muscle cells from human and rabbit penile corpus cavernosum was developed, and cells showed characteristic myocyte morphology and alpha-actin immunoreactivity. The presence of Rho-kinase was demonstrated by indirect immunofluorescence and Western blotting. A specific inhibitor of Rho-kinase, Y-27632, inhibited in a concentration-dependent manner the kinase activity of the protein immunoprecipitated with anti-Rho-kinase antibody. These results demonstrate for the first time expression and activity of Rho-kinase in human penile cavernosal smooth muscle cells and suggest that these cells can provide a cellular model for the study of enzymes involved in Ca2+-sensitizing pathways.
Collapse
Affiliation(s)
- R W Rees
- Wolfson Institute for Biomedical Research, University College London, Gower Street, London, UK
| | | | | | | | | | | |
Collapse
|
29
|
Rees RW, Ralph DJ, Royle M, Moncada S, Cellek S. Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum. Br J Pharmacol 2001; 133:455-8. [PMID: 11399661 PMCID: PMC1572821 DOI: 10.1038/sj.bjp.0704124] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
We have examined the effect of an inhibitor of Rho-kinase, (+)-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl) cyclohexanecarboxamide dihydrochloride monohydrate (Y-27632), on the contractions elicited by noradrenergic nerve stimulation and by phenylephrine in the human and rabbit penile corpus cavernosum. In both tissues, after treatment with scopolamine (10 microM) and N(G)-nitro-L-arginine methyl ester (L-NAME; 300 microM), electrical field stimulation (EFS) elicited noradrenergic contractions. These contractions were inhibited by Y-27632 in a concentration-dependent manner. The compound caused concentration-dependent relaxation of phenylephrine-contracted tissues, which were treated with scopolamine (10 microM), guanethidine (10 microM) and L-NAME (300 microM). These results suggest that Rho-kinase is involved in noradrenergic contractile pathway in the cavernosal smooth muscle of the penis.
Collapse
Affiliation(s)
- Rowland W Rees
- The Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6AE
- Institute of Urology, Middlesex Hospital, London W1W 7EL, UK
| | - David J Ralph
- Institute of Urology, Middlesex Hospital, London W1W 7EL, UK
| | | | - Salvador Moncada
- The Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6AE
| | - Selim Cellek
- The Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6AE
- Author for correspondence:
| |
Collapse
|
30
|
Rees RW, Feigel I, Vickers A, Zollman C, McGurk R, Smith C. Prevalence of complementary therapy use by women with breast cancer. A population-based survey. Eur J Cancer 2000; 36:1359-64. [PMID: 10899648 DOI: 10.1016/s0959-8049(00)00099-x] [Citation(s) in RCA: 111] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
The study measured the prevalence and costs of complementary therapy use by women diagnosed with breast cancer in the South Thames NHS region. A postal questionnaire was sent to a sample of 1023 women from the Thames Cancer Registry who had been diagnosed with breast cancer in the previous 7 years. Just over a fifth (22.4%) had consulted a complementary practitioner in the previous 12 months. Almost one third (31.5%) had done so since diagnosis. Almost pound17000 had been spent on visits in the previous year. The women using complementary medicine after diagnosis were slightly younger, more educated and more likely to have used complementary medicine before their diagnosis than non-complementary medicine users. In conclusion, significant numbers of women are visiting complementary therapists for health reasons following a breast cancer diagnosis. The out of pocket costs per user, with notable exceptions, are modest. Use of practitioners of complementary therapies following diagnosis is a significant and possibly growing phenomenon.
Collapse
Affiliation(s)
- R W Rees
- SSRU, Institute of Education, University of London, 18 Woburn Square, WC1H 0NS, London, UK.
| | | | | | | | | | | |
Collapse
|
31
|
Smith CC, Archer GE, Forster EJ, Lambert TR, Rees RW, Lynch AM. Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in MutaMouse. Environ Mol Mutagen 1999; 34:131-139. [PMID: 10529737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
The mutagenicity and clastogenicity of the immunosuppressive drug azathioprine (AZA), a multitissue rodent carcinogen and IARC-classified human carcinogen, was investigated using transgenic lacZ mice (MutaMouse). Male animals (n = 5 per group) were dosed with AZA (10, 50, 100 mg/kg p.o. daily for 5 days), vehicle (n = 10), or the positive control, chlorambucil (15 mg/kg i.p., n = 3), and killed 24 hr or 25 days after the last treatment. Micronucleus assays were performed with bone marrow (24-hr samples) or peripheral blood (24-hr and 25-day samples) and DNA was extracted from bone marrow and liver for gene mutation analysis at the transgenic lacZ locus. AZA induced 5.3-111.3-fold increases in %MNPCE (P < 0.01) in bone marrow compared with vehicle control, accompanied by 4.4-5. 6-fold increases in %MNRETs (P < 0.01) in peripheral blood. Chlorambucil caused a 14.5-fold increase in %MNRET and there was evidence of significant stem cell toxicity in both positive control and AZA treatment groups. By day 25, however, there was evidence of substantial recovery of the bone marrow as determined by the frequency of RET, and the %MNRET in all treatment groups was the same as the vehicle control. Analysis of lacZ MF showed 1.4-1.6-fold increases in AZA 24-hr bone marrow samples, increasing to approximately 2.0-fold above concurrent controls by day 25 (medium dose P < 0.05, high dose P < 0.01). For liver, there was a 2-fold increase in MF (P < 0.05) in the 24-hr sample at the highest dose only, and increases of 1.3-1.5-fold by day 25 in the medium (P < 0. 05) and high (P = 0.055) dose groups, respectively. The positive control, chlorambucil, induced 2-3-fold increases (P < 0.01) in mean MF in both bone marrow (25-day sample) and liver (24-hr and 25-day samples). These data confirm the clastogenicity of AZA in the mouse, and show that this compound induces gene mutations in bone marrow and liver, in vivo, at the highest dose and supports the view that AZA is a genotoxic carcinogen.
Collapse
Affiliation(s)
- C C Smith
- SmithKline Beecham Pharmaceuticals, Welwyn, Herts, UK
| | | | | | | | | | | |
Collapse
|
32
|
Vickers AJ, Rees RW, Robin A. Advice given by health food shops: is it clinically safe? J R Coll Physicians Lond 1998; 32:426-8. [PMID: 9819734 PMCID: PMC9663107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
OBJECTIVE To determine whether health shop staff give specific therapeutic recommendations to someone who describes symptoms associated with serious pathology and to determine whether they refer this person to conventional medical care. DESIGN Quantitative survey using participant observation. SETTING Health food shops selling herbal, homeopathic or nutritional remedies in inner London. METHOD A researcher visited 29 health food shops and claimed to be suffering from severe, daily headaches of recent onset. The researcher recorded on tape whether the health shop staff took diagnostic information; recommended any therapeutic intervention; asked about or recommended seeing a general practitioner (GP); asked about use of conventional drugs. Coding of the interactions was carried out independently by two researchers. RESULTS Whereas all but two shops recommended a specific therapeutic intervention, less than one in four advised a GP consultation. Forty-two different interventions were recommended. There was little consistency in the advice given. CONCLUSION Health food shops need to review the circumstances in which they should venture to provide advice and the basis on which they make any therapeutic recommendations. Shops selling over-the-counter herbal, homeopathic and health food products are a common feature of UK high streets. Such shops could be a useful source of health information and advice to their customers, but could also lead to harm, for example by delaying treatment of known benefit, if their recommendations were to be inaccurate or inappropriate.
Collapse
Affiliation(s)
- A J Vickers
- Research Council for Complementary Medicine, London
| | | | | |
Collapse
|
33
|
Amphlett NW, Mitchell ID, Rees RW, Haynes GA. A proposal for a two-dose/single-sample in vivo/in vitro rat hepatocyte unscheduled DNA synthesis assay. Mutagenesis 1996; 11:19-26. [PMID: 8671710 DOI: 10.1093/mutage/11.1.19] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
We have developed a two dose/single-sample protocol for the in vivo/in vitro rat hepatocyte unscheduled DNA synthesis (UDS) assay. In order to enhance the effectiveness of grain detection by image analysis we found minor technical modifications to be beneficial. These included the use of 3% acetic acid in ethanol (or 4% aqueous paraformaldehyde) for hepatocyte fixation and 0.5% aqueous eosin for staining. Also, there was no correlation between cell viability (measured using the trypan blue method) and UDS response and, therefore, we do not reject animals from data analysis unless hepatocyte viability falls below 50%. Furthermore, we suggest that cell attachment is a more reliable indicator of toxicity than of cell viability. Therefore, our range-finding test has been modified to incorporate an extra animal per group so that hepatocyte cultures can be evaluated. Comparisons of a two-dose/single-sample protocol with the currently accepted single-dose/multiple-sample protocol demonstrated that the former was an acceptable alternative, in that responses with standard positive controls are very similar with both protocols. Furthermore, the two-dose protocol has clear advantages in that it uses fewer animals, resources and time and has better statistical discriminatory power. As a move away from the use of arbitrary values for determining the performance and outcome of assays, we use criteria based on confidence limits placed on historical data ranges. Where necessary, statistical analyses of concurrent data is performed using rank transformation followed by parametric analysis of the ranks; this combines the generality of a non-parametric methodology with the power and versatility of parametric analyses.
Collapse
Affiliation(s)
- N W Amphlett
- Toxicology Department, SmithKline Beecham Pharmaceuticals, Welwyn, Herts, UK
| | | | | | | |
Collapse
|
34
|
Thomas JA, Matanhelia SS, Dickson WA, Rees RW, Matthews PN. Use of the rectus abdominis myocutaneous flap in treating advanced carcinomas of the penis. Br J Urol 1995; 75:214-9. [PMID: 7850329 DOI: 10.1111/j.1464-410x.1995.tb07314.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
OBJECTIVE To examine the methods used to obtain skin closure after radical surgery for carcinomas of the penis, with special reference to the rectus abdominis myocutaneous flap. PATIENTS AND METHODS Over a 20 year period, 21 patients underwent surgery for carcinomas of the penis. Seven had advanced tumours, requiring radical surgery for complete local tumour control. The resulting wounds were repaired with scrotal skin transfer in three patients and with a rectus abdominis myocutaneous flap in the other four. RESULTS These methods of repair were a 100% reliable, all wounds being healed within 10 days. CONCLUSIONS Scrotal skin transfer is a simple and effective method of achieving wound closure. Where removal of the scrotum is required along with curative or palliative surgery, and after ilio-inguinal lymphadenectomy, a rectus abdominis myocutaneous flap is useful for skin closure.
Collapse
Affiliation(s)
- J A Thomas
- Department of Urology, University Hospital of Wales, Cardiff, UK
| | | | | | | | | |
Collapse
|
35
|
Mitchell IG, Amphlett NW, Rees RW. Parametric analysis of rank transformed data for statistical assessment of genotoxicity data with examples from cultured mammalian cells. Mutagenesis 1994; 9:125-32. [PMID: 8201945 DOI: 10.1093/mutage/9.2.125] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
The utility of rank transformation followed by parametric analysis of the ranks has been assessed for determination of the statistical significance of genotoxicity data. Both nonparametric and parametric analytical methods have defects when used to assess the significance of results from routine regulatory tests. Superficially, the rank transformation method followed by parametric analysis of ranks appears to be an ideal solution. However, we considered that such a test might suffer a substantial loss of power when used to analyse normally distributed data with very low sample replication. To test this hypothesis we took 22 data sets from five 'borderline' positive compounds in mouse lymphoma treat-and-plate assays where treatment-related increases were between 1.5- and 3-fold the control and analysed these results by Dunnett's t-test using rank transformed data and weighted, untransformed data. In theory these mouse lymphoma data should show the rank transformation system at its worst in comparison with parametric methodology using weighted data. Surprisingly, the rank transformation methodology showed no loss of power and, overall, performed more consistently than the weighted data methodology. Based on this limited number of data sets, rank transformation followed by parametric analysis of ranks seems to be an approach very suitable for genotoxicity assays in general, particularly where distributions are non-normal or of uncertain form. It combines the general applicability of non-parametric methods with the power of parametric analyses. However, the methodology still requires to be further validated in use and by computer simulation.
Collapse
Affiliation(s)
- I G Mitchell
- Toxicology Department, SmithKline Beecham Pharmaceuticals, Welwyn, Hertfordshire, UK
| | | | | |
Collapse
|
36
|
Abstract
The Klippel-Trenaunay syndrome is a rare disorder in which the congenital vascular anomalies can affect the urogenital tract. Several cases of hemorrhage from the urogenital system have been reported in children with this condition. We report an upper renal tract hemorrhage in an adult, which required nephrectomy. To our knowledge this condition has not been reported previously in an adult with the Klippel-Trenaunay syndrome. We discuss the condition, and its diagnosis, treatment and relevance to the urogenital tract.
Collapse
Affiliation(s)
- L J Fligelstone
- Department of Urology, University Hospital of Wales, Heath Park, Cardiff, United Kingdom
| | | | | | | |
Collapse
|
37
|
Fligelstone LJ, Jerwood TE, Thomas JA, Rees RW. Blood contamination of the feet during orthopaedic procedures. Ann R Coll Surg Engl 1994; 76:66-7. [PMID: 8117025 PMCID: PMC2502171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
|
38
|
Thomas JA, Fligelstone LJ, Jerwood TE, Rees RW. Theatre footwear: a health hazard? Br J Theatre Nurs 1993; 3:5-9. [PMID: 8260757] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Theatre footwear frequently appears to be contaminated with blood. We assessed objectively the nature and degree of contamination of theatre shoes after cleaning. Two hundred pairs of theatre shoes were randomly selected from three hospitals in South East Wales. Hospital 1 (H1), 100 pairs of shoes, Hospital 2 (H2), 40, Hospital 3 (H3), 60. They were examined for general appearance, the presence of bacterial pathogens and blood, using a leuchomalachite green assay. The majority of shoes were dirty, 63% in H1, 80% in H2, and 95% in H3. Six per cent of shoes in H1, 2.5% in H2 and 0% in H3 were contaminated with staphylococcus aureus. No shoes were contaminated with pseudomonas aeruginosa. Thirty six per cent of shoes in H1, 40% in H2 and 57% in H3 were contaminated with blood. In H1 it was possible to determine the grade of staff to whom the shoes belonged. Fifty eight per cent of consultant surgeons' shoes tested positive for blood, 50% of junior surgeons, 16% of operating department assistants and none of nurses' theatre shoes. The high level of blood contamination following cleaning may pose a potential HIV or hepatitis B risk to patients, manual shoe cleaner and surgeons. We have demonstrated that current shoe cleaning practices are ineffective. We propose methods that should eliminate this risk. Procedures will need to be defined.
Collapse
|
39
|
Affiliation(s)
- N A Burgess
- Department of Urology, University Hospital of Wales, Cardiff
| | | | | |
Collapse
|
40
|
Buck AC, Cox R, Rees RW, Ebeling L, John A. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study. Br J Urol 1990; 66:398-404. [PMID: 1699628 DOI: 10.1111/j.1464-410x.1990.tb14962.x] [Citation(s) in RCA: 86] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Whilst prostatectomy remains the "gold standard" for the treatment of outflow tract obstruction due to benign prostatic hyperplasia, medical treatment--if only for symptomatic relief--appears to be an attractive alternative. Most of the pharmacological agents in use block the hormonal or the sympathetic neurological pathways that influence prostate growth and function. All of these drugs are known to have side effects. Sixty patients with outflow obstruction due to benign prostatic hyperplasia (BPH) were entered into a double-blind, placebo-controlled study to evaluate the effect of a 6-month course of the pollen extract, Cernilton. There was a statistically significant subjective improvement with Cernilton (69% of the patients) compared with placebo (30%). There was a significant decrease in residual urine in the patients treated with Cernilton and in the antero-posterior (A-P) diameter of the prostate on ultrasound. However, differences in respect of flow rate and voided volume were not statistically significant. It is concluded that Cernilton has a beneficial effect in BPH and may have a place in the treatment of patients with mild or moderate symptoms of outflow obstruction.
Collapse
Affiliation(s)
- A C Buck
- Department of Urology, University Hospital of Wales, Cardiff
| | | | | | | | | |
Collapse
|
41
|
Mitchell ID, Rees RW, Gilbert PJ, Carlton JB. The use of historical data for identifying biologically unimportant but statistically significant results in genotoxicity assays. Mutagenesis 1990; 5:159-64. [PMID: 2188068 DOI: 10.1093/mutage/5.2.159] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
The definition of a negative result is a problem in genetic toxicology. Here we suggest that a result may be considered biologically unimportant (negative) if it falls within the limits of variation usually found in the negative controls of the particular test. To determine 'usual' variation, we have set 95% confidence limits on three indices of variation, calculated from historical values for duplicate negative control data from several genotoxicity tests. These tests showed four characteristic types of response and the appropriate index of variability was determined for each. Where there was little test-to-test variation in true mean (micronucleus test and metaphase analysis), confidence limits set on the overall distribution of negative controls were the best index of variability. In other assays (Ames, yeast and mouse lymphoma), there was considerable test-to-test variation so that differences between, or ratios of, the members of control duplicates were the preferred measure of variability. This approach can define what is biologically unimportant in terms of the test system. However, no inference can be drawn as to potential importance. Thus the main use is the removal of the positive 'label' from statistically significant results which fall within the usual range of spontaneous variation for the assay under consideration.
Collapse
Affiliation(s)
- I D Mitchell
- Beecham Pharmaceuticals Research Division, Nr Ingatestone, Essex, UK
| | | | | | | |
Collapse
|
42
|
Abstract
Chronic abacterial prostatitis and prostatodynia are notoriously difficult both to diagnose and to treat. These patients tend to have received several courses of antibiotics, antiinflammatory agents or adrenergic blockade and various other therapeutic manoeuvres with little success. The pollen extract, Cernilton, is reported to be effective in the treatment of this condition and we present the results of an open trial with Cernilton in a group of 15 patients with chronic prostatitis and prostatodynia. In 13 patients there was either complete and lasting relief of symptoms or a marked improvement; 2 patients failed to respond. Cernilton was found to be effective in the treatment of chronic prostatitis and prostatodynia. Its precise mode of action is not known, although experimental studies suggest that it has anti-inflammatory and anti-androgenic properties.
Collapse
Affiliation(s)
- A C Buck
- Department of Urology, Leighton Hospital, Crewe
| | | | | |
Collapse
|
43
|
Rees RW, Brice AJ, Carlton JB, Gilbert PJ, Mitchell ID. Optimization of metabolic activation for four mutagens in a bacterial, fungal and two mammalian cell mutagenesis assays. Mutagenesis 1989; 4:335-42. [PMID: 2687626 DOI: 10.1093/mutage/4.5.335] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
The optimum concentrations of Aroclor-induced rat liver S9 microsomal fraction for the mutagenic activity of the four standard mutagens 2-aminofluorene (2-AF), acriflavine (ACR), benzo[a]pyrene (BP) and cyclophosphamide (CP) were determined in four mutation assays. The four assays were the Ames test using Salmonella typhimurium strain TA100, cycloheximide resistance in the yeast Saccharomyces cerevisiae, the mouse lymphoma TK assay and the human peripheral lymphocyte cytogenetic assay. BP was the only mutagen to be most active at comparable S9 concentrations, of approximately 1%, for all four assays. The optimum S9 concentrations for each of the remaining three mutagens varied substantially between the four assays. ACR was a potent direct-acting mutagen in both mammalian cell assays. The mouse lymphoma TK assay results showed similar optimal values of 1.5% S9 or below for each of the four test agents. The assay with the largest variation of optimal S9 values for the four mutagens was the Ames test in strain TA100, although it also had the widest peaks of activity over the range of S9 concentrations tested. It is likely that the diversity of findings is due to a variety of metabolites affecting the different genetic endpoints that are measured in these assays. Thus from these results it is not possible for bacterial optimization data to be related to other routine in vitro systems. The use of more than one concentration of S9 would contribute useful information.
Collapse
Affiliation(s)
- R W Rees
- Beecham Pharmaceuticals Research Division, Essex, UK
| | | | | | | | | |
Collapse
|
44
|
Beacock CJ, Buck AC, Zwinck R, Peeling WB, Rees RW, Turkes A, Walker K, Griffiths K. The treatment of metastatic prostatic cancer with the slow release LH-RH analogue Zoladex ICI 118630. Br J Urol 1987; 59:436-42. [PMID: 2954605 DOI: 10.1111/j.1464-410x.1987.tb04842.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
The clinical and endocrine response to a depot preparation of the LH-RH analogue ICI 118630 (Zoladex) was assessed in 55 untreated patients with advanced prostatic cancer. Whereas gonadal androgen suppression was achieved in all patients, subjective and objective clinical response occurred in only 69%, indicated by a relief of bone pain, a decrease in the size of the primary tumour and lymph node metastases and improvement in bone scan appearances. A third of these patients, however, subsequently showed progression of their disease. Serious side effects were not encountered in this study. The depot formulation is a simple, safe and convenient method of administering Zoladex and offers an alternative treatment for metastatic prostatic cancer.
Collapse
|
45
|
Bowsher WG, Rees RW. Treatment of carcinoma in a solitary kidney: alternative technique. Br J Urol 1987; 59:487-8. [PMID: 3594115 DOI: 10.1111/j.1464-410x.1987.tb04858.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|
46
|
Abstract
A method of measuring residual urine volume using ultrasound is described. The volume is computed from serial parallel sections of the bladder. This method is found to be significantly more accurate than previously reported techniques and is quick and easy to perform.
Collapse
|
47
|
Abstract
The synthesis and in vitro antibacterial activity of (+/-)(cis)-3-[2-(2-aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]- 4-fluoromethyl-2-oxo-1-azetidinesulfonic acid, potassium salt are presented.
Collapse
|
48
|
Abstract
A case of acute urinary retention due to a vesical leiomyoma is described. This is an unusual presentation and the treatment is discussed.
Collapse
|
49
|
|
50
|
Gow JG, Blandy JP, Kinder CH, Lumb GN, Milroy EJ, Rees RW. Report of the Standing Committee on Urological Instruments: Irrigating Resectoscopes. Br J Urol 1982; 54:1-4. [PMID: 7059754 DOI: 10.1111/j.1464-410x.1982.tb13501.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|